Berns Paul Linsider trades

In SEC Form 4 filings, Berns Paul L is listed as See Remarks of Neumora Therapeutics, Inc. (NMRA). Berns Paul L reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Aug 21.

Companies and roles

Company	Role	Transactions	Last filed
NMRANeumora Therapeutics, Inc.	See Remarks	1	Aug 21

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
NMRANeumora Therapeutics, Inc.	Aug 20	Aug 21	A · derivative	500,000	$1.52	$760,000	500,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.